• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL12/CXCR4 抑制作用在恶性胸膜间皮瘤中实验研究。

Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.

机构信息

Thoracic Surgery Department, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

Thoracic Surgery Department, The Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

J Investig Med. 2019 Feb;67(2):338-345. doi: 10.1136/jim-2018-000839. Epub 2018 Oct 26.

DOI:10.1136/jim-2018-000839
PMID:30367010
Abstract

Previous studies have demonstrated that CXCL12/CXCR4 axis is closely related to tumors such as malignant pleural mesothelioma (MPM). This research was conducted in order to detect whether CXCL12/CXCR4 inhibitors could restrain MPM and have a synergistic effect with chemotherapy, also to investigate the relationship of CXCL12/CXCR4 with other gene expressions in MPM. Forty mice were injected MPM cells and randomly divided into four groups: the PBS (control group), AMD3100 (CXCR4-CXCL12 antagonist), pemetrexed and AMD3100 plus pemetrexed. The mice were treated respectively for duration of 3 weeks. The size, bioluminescence and weight of tumors were measured. The differences between gene expressions in each group were analyzed. The tumor weights of each treatment group were lower than that of the control group (p<0.05). The bioluminescence of the tumor of the AMD3100 treatment group and the AMD3100 plus pemetrexed treatment group were lower than that of the control group (p<0.05), and AMD3100 was shown to have synergistic effects with pemetrexed (p<0.05). Among the 2.5 billion genes, several hundreds of genes expressed differently between groups. Results show that AMD3100 and pemetrexed can inhibit the growth of MPM in vivo, also that there is a better result if both are used together. Our findings suggest that CXCL12/CXCR4 axis affects a certain amount of gene expression in MPM.

摘要

先前的研究表明,CXCL12/CXCR4 轴与恶性胸膜间皮瘤(MPM)等肿瘤密切相关。本研究旨在检测 CXCL12/CXCR4 抑制剂是否能抑制 MPM 并与化疗产生协同作用,还研究了 CXCL12/CXCR4 与 MPM 中其他基因表达的关系。将 40 只小鼠注射 MPM 细胞,并随机分为四组:PBS(对照组)、AMD3100(CXCR4-CXCL12 拮抗剂)、培美曲塞和 AMD3100 加培美曲塞。各组分别治疗 3 周。测量肿瘤的大小、生物发光和重量。分析每组基因表达的差异。与对照组相比,各治疗组的肿瘤重量均较低(p<0.05)。AMD3100 治疗组和 AMD3100 加培美曲塞治疗组的肿瘤生物发光均低于对照组(p<0.05),且 AMD3100 与培美曲塞具有协同作用(p<0.05)。在 25 亿个基因中,有数百个基因在组间表达不同。结果表明,AMD3100 和培美曲塞均可抑制 MPM 的体内生长,两者联合使用效果更佳。我们的研究结果表明,CXCL12/CXCR4 轴影响 MPM 中一定数量的基因表达。

相似文献

1
Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.CXCL12/CXCR4 抑制作用在恶性胸膜间皮瘤中实验研究。
J Investig Med. 2019 Feb;67(2):338-345. doi: 10.1136/jim-2018-000839. Epub 2018 Oct 26.
2
The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma.CXCR4、CXCL12 和 CXCR7 在恶性胸膜间皮瘤中的表达。
J Pathol. 2011 Mar;223(4):519-30. doi: 10.1002/path.2829. Epub 2011 Jan 5.
3
CXCR4+FOXP3+CD25+ lymphocytes accumulate in CXCL12-expressing malignant pleural mesothelioma.CXCR4+FOXP3+CD25+淋巴细胞在表达CXCL12的恶性胸膜间皮瘤中积聚。
Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):43-51. doi: 10.1177/039463200902200106.
4
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.载培美曲塞纳米粒靶向恶性胸膜间皮瘤细胞的体外研究。
Int J Nanomedicine. 2019 Jan 23;14:773-785. doi: 10.2147/IJN.S186344. eCollection 2019.
5
Combination effect of photodynamic therapy using NPe6 with pemetrexed for human malignant pleural mesothelioma cells.使用NPe6的光动力疗法与培美曲塞联合对人恶性胸膜间皮瘤细胞的作用
Int J Oncol. 2015 Feb;46(2):741-9. doi: 10.3892/ijo.2014.2746. Epub 2014 Nov 10.
6
Gli as a novel therapeutic target in malignant pleural mesothelioma.Gli 作为恶性胸膜间皮瘤的新型治疗靶点。
PLoS One. 2013;8(3):e57346. doi: 10.1371/journal.pone.0057346. Epub 2013 Mar 6.
7
Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.在化疗耐药性恶性胸膜间皮瘤中,内质网应激诱导未折叠蛋白反应的激活会导致细胞凋亡敏感性增加。
Br J Cancer. 2018 Jul;119(1):65-75. doi: 10.1038/s41416-018-0145-3. Epub 2018 Jun 20.
8
Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.叶酸表型(FAP)是预测恶性胸膜间皮瘤中基于培美曲塞化疗反应的一种更优生物标志物。
Oncotarget. 2017 Jun 6;8(23):37502-37510. doi: 10.18632/oncotarget.16398.
9
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.生长激素释放激素(GHRH)拮抗剂抑制人恶性胸膜间皮瘤的生长。
Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2226-2231. doi: 10.1073/pnas.1818865116. Epub 2019 Jan 18.
10
Pemetrexed Maintenance Therapy Following Bevacizumab-Containing First-Line Chemotherapy in Advanced Malignant Pleural Mesothelioma: A Case Report and Literatures Review.贝伐单抗一线化疗后培美曲塞维持治疗晚期恶性胸膜间皮瘤:一例报告及文献复习
Medicine (Baltimore). 2016 Apr;95(14):e3351. doi: 10.1097/MD.0000000000003351.

引用本文的文献

1
The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity.自分泌的CXCR4/CXCL12轴通过调节肺成纤维细胞活性促进肺纤维化。
Exp Ther Med. 2020 Mar;19(3):1844-1854. doi: 10.3892/etm.2020.8433. Epub 2020 Jan 8.